The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Schreiber, Hans
One or more keywords matched the following items that are connected to Schreiber, Hans
Item TypeName
Concept Neoplasm Transplantation
Academic Article Genetically engineered vaccines. Comparison of active versus passive immunotherapy against solid tumors.
Academic Article Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
Academic Article Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation.
Academic Article Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.
Academic Article Priming of naive T cells inside tumors leads to eradication of established tumors.
Academic Article IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.
Academic Article Cancer. Awakening immunity.
Academic Article Unique tumor-specific antigens.
Academic Article Identification of a gene encoding a tumor-specific antigen that causes tumor rejection.
Academic Article Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.
Academic Article CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells.
Academic Article CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes.
Academic Article Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
Academic Article Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.
Academic Article CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.
Academic Article Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
Academic Article In vivo administration of anti-CD3 prevents malignant progressor tumor growth.
Academic Article Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors.
Search Criteria
  • Neoplasm Transplantation